Deals
Insight(1/5)
Big Pharma hungry for biotech deals
Even amid aggressive cost-cutting, many big pharmaceutical companies continue to seek biotech acquisitions in the hope of finding new drugs to replace those lost to generic competition. Full Article
Assets could be a tough sell for S.Korea
South Korea may have to offer steep discounts to sell key state assets such as bank stakes, to help cut a growing fiscal deficit, while pumping money into the economy to pull it safely out of a global downturn. Full Article
Investors ask courts for bigger piece of pie
Hedge funds, private equity firms and institutional investors left on the sidelines in pre-bankruptcy negotiations are asking the courts to let them help divide up the remains anyway. Full Article
TPG to invest in Japan Airlines?
Private equity company TPG's possible minority investment would be aimed at preventing JAL from defecting to a rival group, the chief financial officer of American Airlines parent AMR said. Full Article
AIG could weather CEO departure
American International Group's tough talking chief executive has reportedly threatened to quit, but the giant insurer, which is showing signs of life after its brush with bankruptcy last year, could do fine without him. Full Article
The strength and durability of the expansion is in question. 
Global Deals Data
The Buzz
- peHUB
Top Deals Stories by Region
- Americas
- Europe
- Asia
Get Deals Today Delivered Daily
video
Business Update: Asia up, gold peak
Nov 12 - Asian shares rally for a fifth session, while a weak U.S. dollar sends gold to another record peak. Play Video
|
Target:
Advent Capital Holdings Plc (GBR) Acquirer: Fairfax Financial Holdings Ltd (CAN) |
Spread: 4.851519% |
|
Target:
Affiliated Computer Services Inc (USA) Acquirer: XEROX CORP (USA) |
Spread: 6.663018% |
|
Target:
Agree Realty Corp (USA) Acquirer: Compson Holding Corp (USA) |
Spread: 16.229925% |
Global Inflows/Outflows
Deals News by Industry
Pfizer says absorbing Wyeth at top speed
NEW YORK (Reuters) - Pfizer Inc Chief Executive Officer Jeffrey Kindler said the drugmaker is integrating its Wyeth purchase far faster than previous big acquisitions, and it will no longer be overly dependent on one or two blockbuster medications. Full Article
Reuters Conferences
| Event | Date | Location |
|---|---|---|
| Buyouts Texas 2009 | 15 Oct | Dallas |
| EVCJ Fundraising Forum 2009 | 3 Nov | London |
| Hedge Funds: How to Find the Right Prime Broker | 10 Nov | Webinar |
| Buyouts West 2009 | 19 Nov | Los Angeles |
| Hedge Funds: Emerging Manager Fund Raising | 15 Dec | Webinar |
